Microscopic image of tuberculosis-infected lung
The Bay Area research community is invited to learn about the latest research on multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR TB) at a symposium on Wednesday, Oct. 3.
The symposium is scheduled from 8 to 10 a.m. on Wednesday, Oct. 3, with opening remarks by Warner Greene, MD, PhD, co-director of CFAR, at Carr Auditorium at San Francisco General Hospital (SFGH). Check-in will begin at 7:30 a.m. and refreshments will be served.
The symposium is sponsored by the UCSF-Gladstone Institute of Virology and Immunology (GIVI), Center for AIDS Research (CFAR) 2007-2008 Directors' Research Seminar Series, together with the SFGH HIV Grand Rounds.
Featured speakers include Gerald Friedland, MD, director of the AIDS Program, Yale School of Medicine, Charles L. Daley, MD, of the National Jewish Medical and Research Center, and L. Masae Kawamura, MD, director of TB Control in the San Francisco Department of Public Health.
The event will be hosted by Diane Havlir, MD, chief of the HIV/AIDS division at SFGH, and co-hosted by Philip Hopewell, MD, director of the Francis J. Curry National Tuberculosis Center at UCSF.
Friedland was among the first to recognize and report on the critically important appearance of XDR TB in an HIV-infected person in Durban, South Africa. XDR TB has an extremely high mortality rate in the HIV-coinfected population.
Concern about XDR TB was raised in the recently publicized case of the patient from the United States who flew on airlines with what was feared to be this highly resistant disease form. Daley, a former UCSF faculty member, was this patient's physician and was a spokesman for the case. The discussion promises to be lively and informative.
Registration is via email and admission is free. For more information or to register, please contact
Brenda Sanchez (CFAR) or visit the Directors'
Research Seminar Series page.
